Pathogenicity of GBV-C/HGV infection

被引:2
|
作者
Müller, C [1 ]
机构
[1] Univ Vienna, Klin Innere Med 4, Klin Abt Gastroenterol & Hepatol, Allgemeines Krankenhaus, A-1090 Vienna, Austria
关键词
CBV-C/HGV infection; post-transfusion hepatitis; community-acquired hepatitis; pathogenicity;
D O I
10.1046/j.1365-2893.1999.00009.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Extensive studies of GBV-C/HGV in acute and chronic hepatitis non-A-non-E have failed to provide hard evidence for a major role in this disease. Persistent GBV-C/HGV viraemia is in most cases associated with normal ALT levels, and only in a minority of patients are mild elevations of aminotransferases found. Its disease-inducing capacity is questionable and the findings accumulated so far are best explained by looking at GBV-C/HGV as a well-adapted, predominantly parenterally transmitted, persistent virus; it might be transmitted concomitantly with another, still unidentified hepatitis non-A-non-E virus. This does not exclude the possibility that GBV-C/HGV might, in some rare cases and under certain circumstances, induce a hepatitis-like illness as seen with other viruses such as EBV or CMV, GBV-C/HGV definitely plays a minor role only, if any, in post-transfusion and community-acquired hepatitis non-A-non-E.
引用
下载
收藏
页码:49 / 52
页数:4
相关论文
共 50 条
  • [31] Detection and genotyping of GBV-C/HGV variants in China
    Lu, L
    Ng, MH
    Zhou, BP
    Luo, HT
    Nakano, T
    Robertson, BH
    Im, SWK
    VIRUS RESEARCH, 2001, 73 (02) : 131 - 144
  • [32] GBV-C/HGV病毒学特征
    常锦红
    国际病毒学杂志, 1997, (03) : 76 - 79
  • [33] HGV/GBV-C与HCV混合感染者HGV/GBV-C复制中间体的研究
    聂青和
    胡大荣
    李梦东
    细胞与分子免疫学杂志, 2000, (04) : 332 - 335
  • [34] Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or C
    Yang, JF
    Dai, CY
    Chuang, WL
    Lin, WY
    Lin, ZY
    Chen, SC
    Hsieh, MY
    Wang, LY
    Tsai, JF
    Chang, WY
    Yu, ML
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2006, 59 (01) : 25 - 30
  • [35] Clinical significance of HGV/GBV-C infection and its epidemiology in Ontario, Canada.
    Feinman, SV
    Blajchman, MA
    Hess, G
    Kim, JP
    DSilva, L
    Krajden, M
    Mazuli, A
    Sooknanen, R
    HEPATOLOGY, 1997, 26 (04) : 1352 - 1352
  • [36] Hepatitis HGV/GBV-C viremia in renal transplant recipients
    Lustig, S
    Zemel, R
    Dickman, R
    Yussim, A
    BenAri, Z
    Boner, G
    Shapira, Z
    Hodges, S
    Traylor, D
    TurKaspa, R
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (06) : 2694 - 2695
  • [37] Detection of GBV-C/HGV viremia in hemophiliac patients.
    Taoufik, Y
    Revel, R
    Laurian, Y
    Dussaix, E
    HEPATOLOGY, 1996, 24 (04) : 1838 - 1838
  • [38] GBV-C/HGV in hemodialysis patients:: Anti-E2 antibodies and GBV-C/HGV-RNA in serum and peripheral blood mononuclear cells
    Tribl, B
    Oesterreicher, C
    Pohanka, E
    Sunder-Plassmann, G
    Petermann, D
    Müller, C
    KIDNEY INTERNATIONAL, 1998, 53 (01) : 212 - 216
  • [39] Hepatitis HGV/GBV-C in New Zealand blood donors
    Woodfield, G
    Mayumi, M
    NEW ZEALAND MEDICAL JOURNAL, 1997, 110 (1040) : 108 - 108
  • [40] The role of GBV-C/HGV in fulminant hepatic failure.
    Takikawa, Y
    Suzuki, K
    Endo, R
    Iwai, M
    Abe, K
    Ishikawa, K
    Sato, S
    GASTROENTEROLOGY, 1998, 114 (04) : A1352 - A1352